The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Update

9 Sep 2019 07:00

RNS Number : 5794L
MXC Capital Limited
09 September 2019
 

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

MXC Capital Limited

("MXC" or the "Company")

 

Pre-close Trading Update, Proposed Demerger of Transactional Businesses and Proposed Tender Offer

 

MXC (AIM: MXCP), the technology focused adviser and investor, is pleased to provide an update on trading for the year ended 31 August 2019 and other corporate matters.

 

Financial Summary

 

The Company expects to report a profit at Trading EBITDA level1 of no less than £1.7m for the year (2018: loss of £1.2 million). This return to trading profit has been delivered as a result of the combination of management fees from the joint venture with Liberty Global plc ("LGJV") and the partnership with Ravenscroft Limited to advise the GIF Technology & Innovation Cell (the "GIF") in addition to transaction and consultancy fees and loan interest. These revenue streams have continued into the current year.

 

The Company confirms that as at 31 August 2019 it had an unaudited Net Asset Value2 ("NAV") of 116 pence per share (31 August 2018: 95 pence per share) with the underlying portfolio and liquid assets3 valued at 103 pence per share (31 August 2018: 80.5 pence per share). Cash as at 31 August 2019 amounted to £21.5 million. The Company has a strong pipeline of investment opportunities and expects that the majority of the cash will be invested within the next few months.

 

Progress with Investments

 

In terms of our quoted investments, both Adept4 plc ("AD4") and IDE Group Holdings plc ("IDE") have stabilised and have begun their journey of recovering the previously lost value.

 

With respect to our partnerships, LGJV successfully completed two additional transactions and now has a solid platform of monthly profitability. Additional deals continue to be reviewed. The GIF is substantially invested with a current pipeline that should see the fund fully invested or committed by the end of this calendar year. Dialogue has commenced with the shareholders of the GIF about a follow-on fund leading to potential further management fees in the future.

 

Proposed Demerger of Transactional Businesses

 

In September 2018, MXC announced the sale of 25% of the issued share capital of MXC Capital UK Limited ("MXCUK") to Ravenscroft Holdings Limited which valued the division at £9 million. MXCUK is a subsidiary of MXC and is the holding company of the Group's transactional businesses which receive the management, transactional and consultancy fees generated by the Group. The value of this division is not fully reflected in MXC's NAV and hence the Board is proposing to demerge this business into a new company and list this company on The International Stock Exchange in Guernsey ("TISE"). Should the proposed demerger be approved by shareholders, all existing shareholders in MXC will receive their pro-rata allocation of shares in the new company and its shares will be able to be traded on TISE. It is anticipated that the demerged business will be dividend paying. A circular will be sent to shareholders in due course with further details about the proposed demerger and subsequent listing on TISE and requesting shareholder approval.

 

Proposed Tender Offer

 

MXC is pleased to announce that the Board has decided to reward shareholder loyalty by reviving its policy of returning capital to shareholders. The Board's intention is to establish a progressive policy which will see capital being returned to shareholders by way of periodic tender offers. The mechanism of a tender offer gives shareholders the flexibility to either realise a return by allowing the Company to purchase a portion of their shares for cash, or to retain a potentially larger relative holding in the Company so that they might further benefit from any future capital growth. The proposed amount for this year's tender offer is equivalent to the trading profit for the Group, being £1.7 million, and, subject to shareholder approval, is expected to be paid out in October this year. The price for the tender offer will be 116 pence per share, being the NAV per share as at 31 August 2019. A circular will be sent to shareholders giving further detail of the proposed tender offer and the expected timetable shortly.

 

Peter Rigg, Chairman of MXC, commented:

 

"The year to 31 August 2019 saw significant progress for MXC both in terms of trading profitability and with respect to its investments. Post a couple of difficult years, I am delighted that the hard work of the MXC team is paying off and that we can reward shareholders for their loyalty by way of a return of capital. Furthermore, the Board believes that the proposed demerger of the Group's transactional businesses into a separate listed company will give shareholders the opportunity to benefit from the value in these businesses which is currently not fully recognised in MXC's NAV or its share price. We look forward to the coming years with confidence."

 

 

1 earnings from trading activities before interest payable, tax, depreciation, amortisation, non-recurring and exceptional items, share-based payments and movements in fair value of investments and after interest income under the effective interest method as this is considered to be part of the trading activities of the Group

2 total balance sheet net assets plus market value of shares held in the Employee Benefit Trust as at 31 August 2019

3 comprises cash balances, investments, outstanding loan capital and accrued interest and the market value of shares held in the Employee Benefit Trust as at 31 August 2019

 

MXC Capital Limited

Ian Smith

+44 (0) 20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

Nick Cowles, Dan Bate

+44 (0) 161 831 1512

About MXC Capital Limited www.mxccapital.com

MXC is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSLFDWFUSELU
Date   Source Headline
19th May 20172:34 pmRNSTransaction in Own Shares / Total Voting Rights
16th May 20171:40 pmRNSTransaction in Own Shares / Total Voting Rights
15th May 201711:46 amRNSTransaction in Own Shares / Total Voting Rights
12th May 201712:08 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 201712:35 pmRNSTransaction in Own Shares/ Total Voting Rights
11th May 20179:52 amRNSTransaction in Own Shares/ Total Voting Rights
10th May 20177:26 amRNSInterim Results
5th May 20177:16 amRNSTransaction in Own Shares / Total Voting Rights
3rd Apr 20177:00 amRNSExtension of Share Buyback Programme
29th Mar 20173:18 pmRNSTransaction in Own Shares / Total Voting Rights
28th Mar 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
27th Mar 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
24th Mar 20174:44 pmRNSTransaction in Own Shares/ Total Voting Rights
22nd Mar 201711:16 amRNSTransaction in Own Shares / Total Voting Rights
21st Mar 20176:29 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 20172:20 pmRNSTransaction in Own Shares / Total Voting Rights
20th Mar 201711:08 amRNSTransaction in Own Shares / Total Voting Rights
17th Mar 20176:17 pmRNSTransaction in Own Shares / Total Voting Rights
16th Mar 201710:24 amRNSTransaction in Own Shares / Total Voting Rights
15th Mar 20179:18 amRNSTransaction in Own Shares / Total Voting Rights
14th Mar 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
13th Mar 201711:04 amRNSTransaction in Own Shares / Total Voting Rights
10th Mar 20171:23 pmRNSTransaction in Own Shares / Total Voting Rights
10th Mar 201710:48 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 201710:11 amRNSTransaction in Own Shares / Total Voting Rights
9th Mar 20177:00 amRNSTrading Update
8th Mar 20177:00 amRNSIssue of Equity / Total Voting Rights
3rd Mar 20173:12 pmRNSSale of Redcentric Shares
3rd Mar 201710:47 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
3rd Mar 201710:06 amRNSSale of Redcentric Shares
2nd Mar 20179:39 amRNSTransaction in Own Shares / Total Voting Rights
1st Mar 20174:43 pmRNSTransaction in Own Shares / Total Voting Rights
1st Mar 201710:00 amRNSSale of Redcentric Shares
24th Feb 20172:31 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Feb 201710:33 amRNSTransaction in Own Shares / Total Voting Rights
22nd Feb 201711:50 amRNSTransaction in Own Shares / Total Voting Rights
6th Feb 20173:22 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
6th Feb 20172:00 pmRNSSale of Redcentric Shares
26th Jan 20172:39 pmRNSResult of AGM
26th Jan 20172:18 pmRNSNotice of AGM
23rd Jan 20177:00 amRNSExercise of Redcentric Options
10th Jan 20179:42 amRNSPosting of Annual Report and Accounts
6th Jan 20174:30 pmRNSTransaction in Own Shares
5th Jan 20173:57 pmRNSTransaction in Own Shares
3rd Jan 20171:34 pmRNSTransaction in Own Shares
23rd Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 201611:16 amRNSTransaction in Own Shares
22nd Dec 20169:14 amRNSShare Buyback Programme
1st Dec 20167:00 amRNSFinal Results
23rd Nov 20167:00 amRNSResignation as Financial Adviser to Redcentric

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.